Investing.com - Financial Markets Worldwide
NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

InMode to Present at Upcoming Investor Conferences and Events

Published 03/04/2024, 11:58 pm
INMD
-

YOKNEAM, Israel, April 3, 2024 /PRNewswire/ -- InMode (NASDAQ:INMD) Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in April and May:

23rd Annual Needham Virtual Healthcare Conference
Presenters: Moshe Mizrahy, Chief Executive Officer and Chairman, Yair Malca, Chief Financial Officer and Spero Theodorou, Chief Medical Officer
Format:  Virtual fireside chat moderated by Michael Matson (NYSE:MATX), CFA and Senior Equity Research Analyst and one-on-one meetings
When: Tuesday, April 9 at 8:00 am ET
A live webcast of the presentation can be accessed here.

BNPP Exane 2nd Annual Aesthetics Day
Presenters:  Moshe Mizrahy, Chief Executive Officer, Yair Malca, Chief Financial Officer, and Dr. Spero Theodorou, Chief Medical Officer
Format:  Virtual fireside chat moderated by Navann Ty, Lead Equity Analyst and one-on-one meetings
When: Tuesday, May 21 at 1:30 pm ET
A replay of webcast of the presentation can be accessed here.

Barclays (LON:BARC) West Coast Bus Trip
Presenters: Yair Malca, Chief Financial Officer
Format:  In-person investor bus tour at InMode's North American headquarters
When: Tuesday, May 21
Location: Irvine, CA

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654  

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.